Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 2 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Completed 4 Active not recruiting 4 Recruiting 3 Withdrawn 1 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 41 Carcinoma, Non-Small-Cell Lung 28 Colorectal Neoplasms 16 Neoplasms 13 Nasopharyngeal Carcinoma 11 Lung Neoplasms 10 Leukemia, Myeloid, Acute 10 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Prostatic Neoplasms 9 Ovarian Neoplasms 8 Multiple Myeloma 8 Squamous Cell Carcinoma of Head and Neck 7 Small Cell Lung Carcinoma 7 Rectal Neoplasms 7 Esophageal Neoplasms 7 Triple Negative Breast Neoplasms 6 Pancreatic Neoplasms 6 Non-Muscle Invasive Bladder Neoplasms 6 Uterine Cervical Neoplasms 5 Recurrence 5 Neoplasm Metastasis 5 Glioblastoma 5 Colonic Neoplasms 5 Brain Neoplasms 5 Adenocarcinoma 5 Urinary Bladder Neoplasms 4 Polycystic Ovary Syndrome 4 Lymphoma, Follicular 4 Fallopian Tube Neoplasms 4

Interventions

tegafur-gimeracil-oteracil 1 Radiation 1 Oxaliplatin 1 Magnetic Resonance Imaging 1 Leucovorin 1 Irinotecan 1 Induction Chemotherapy 1 Folfox protocol 1 Fluorouracil 1 FOLFOXIRI protocol 1 Endoscopy 1 Colonoscopy 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × Pathologic Complete Response × Clear all

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡